Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data

Genome Biology

Volumn 3, Issue 12, 2002, Pages

  Crawley, Joseph J ^a   Furge, Kyle A ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Comparative Genomic Hybridization; Comparative Genomic Hybridization Analysis; Comparative Genomic Hybridization Data; Cytogenetic Change; Pituitary Tumor Transforming Gene

Indexed keywords

ARTICLE; CELL CULTURE; CHROMOSOME ABERRATION; COMPARATIVE STUDY; COMPUTER PROGRAM; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; SECOND CANCER; STATISTICS;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; NEOPLASMS, SECOND PRIMARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; SOFTWARE; TUMOR CELLS, CULTURED;

EID: 0038581906     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2002-3-12-research0075     Document Type: Article

References (38)

1. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992, 258: 818-821. DOI: 10.1126/science.1359641
2. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R: Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA. 2001, 98: 1124-1129. 10.1073/pnas.98.3.1124. DOI: 10.1073/pnas.98.3.1124
3. Phillips JL, Hayward SW, Wang Y, Vasselli J, Pavlovich C, Padilla-Nash H, Pezullo JR, Ghadimi BM, Grossfeld GD, Rivera A, et al: The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res. 2001, 61: 8143-8149.
4. Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML, Kallioniemi A: Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA. 2001, 98: 5711-5716. 10.1073/pnas.091582298. DOI: 10.1073/pnas.091582298
5. Platzer P, Upender MB, Wilson K, Willis J, Lutterbaugh J, Nosrati A, Willson JK, Mack D, Ried T, Markowitz S: Silence of chromosomal amplifications in colon cancer. Cancer Res. 2002, 62: 1134-1138.
6. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, et al: Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding non-cancerous liver. Proc Natl Acad Sci USA. 2001, 98: 15089-15094. 10.1073/pnas.241522398. DOI: 10.1073/pnas.241522398
7. Hughes TR, Roberts CJ, Dai H, Jones AR, Meyer MR, Slade D, Burchard J, Dow S, Ward TR, Kidd MJ, et al: Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet. 2000, 25: 333-337. 10.1038/77116. DOI: 10.1038/77116
8. Haddad R, Furge KA, Miller J, Schoumans J, Haab B, Teh B, Barr L, Webb C: Genomic profiling and cDNA microarray analysis of human colon adenocarcinoma and associated peritoneal metastasis reveals consistent cytogenetic and transcriptional aberrations associated with progression of multiple metastases. Appl Genomics Proteomics. 2002, 1: 123-134.
9. Pisani P, Parkin DM, Ferlay J: Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer. 1993, 55: 891-903. DOI: 10.1002/ijc.2910550604
10. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993, 54: 594-606. DOI: 10.1002/ijc.2910540413
11. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A: Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 1997, 18: 59-65. 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0. DOI: 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0
12. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JW, Johnson PJ: Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol. 1999, 154: 37-43. DOI: 10.1016/S0002-9440(10)65248-0
13. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai K, Dudoit S, Ng I, Rijn M, et al: Gene expression patterns in human liver cancer. Mol Biol Cell. 2002, 13: 1929-1939. 10.1091/mbc.02-02-0023. DOI: 10.1091/mbc.02-02-0023.
14. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, Dwight SS, Kaloper M, Weng S, Jin H, Ball CA, et al: The Stanford Microarray Database. Nucleic Acids Res. 2001, 29: 152-155. 10.1093/nar/29.1.152. DOI: 10.1093/nar/29.1.152
15. Wong N, Lai P, Pang E, Fung LF, Sheng Z, Wong V, Wang W, Hayashi Y, Perlman E, Yuna S, et al: Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin Cancer Res. 2000, 6: 4000-4009.
16. Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K: Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology. 1999, 29: 1858-18562. DOI: 10.1002/hep.510290636
17. Marchio A, Pineau P, Meddeb M, Terris B, Tiollais P, Bernheim A, Dejean A: Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene. 2000, 19: 3733-3738. 10.1038/sj.onc.1203713. DOI: 10.1038/sj.onc.1203713
18. Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, Liang Q, Li H, Zhou H, Trent JM: Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 2000, 29: 110-116. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1022>3.0.CO;2-V. DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1022>3.0.CO;2-V
19. Zondervan PE, Wink J, Alers JC, Ijzermans JN, Schalm SW, de Man RA, van Dekken H: Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol. 2000, 192: 207-215. 10.1002/1096-9896(2000)9999:9999<::AID-PATH690>3.0.CO;2-#. DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH690>3.0.CO;2-#
20. Tornillo L, Carafa V, Richter J, Sauter G, Moch H, Minola E, Gambacorta M, Bianchi L, Vecchione R, Terracciano LM: Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J Pathol. 2000, 192: 307-312. 10.1002/1096-9896(2000)9999:9999<::AID-PATH706>3.0.CO;2-O. DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH706>3.0.CO;2-O
21. Collonge-Rame MA, Bresson-Hadni S, Koch S, Carbillet JP, Blagosklonova O, Mantion G, Miguet JP, Heyd B, Bresson JL: Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2001, 127: 49-52. 10.1016/S0165-4608(00)00421-0. DOI: 10.1016/S0165-4608(00)00421-0
22. Niketeghad F, Decker HJ, Caselmann WH, Lund P, Geissler F, Dienes HP, Schirmacher P: Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer. 2001, 85: 697-704. 10.1054/bjoc.2001.1963. DOI: 10.1054/bjoc.2001.1963
23. Koo SH, Ihm CH, Kwon KC, Park JW, Kim JM, Kong G: Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet Cytogenet. 2001, 130: 22-28. 10.1016/S0165-4608(01)00460-5. DOI: 10.1016/S0165-4608(01)00460-5
24. Kitay-Cohen Y, Amiel A, Ashur Y, Fejgin MD, Herishanu Y, Afanasyev F, Bomstein Y, Lishner M: Analysis of chromosomal aberrations in large hepatocellular carcinomas by comparative genomic hybridization. Cancer Genet Cytogenet. 2001, 131: 60-64. 10.1016/S0165-4608(01)00492-7. DOI: 10.1016/S0165-4608(01)00492-7
25. Chang J, Kim NG, Piao Z, Park C, Park KS, Paik YK, Lee WJ, Kim BR, Kim H: Assessment of chromosomal losses and gains in hepatocellular carcinoma. Cancer Lett. 2002, 182: 193-202. 10.1016/S0304-3835(02)00083-6. DOI: 10.1016/S0304-3835(02)00083-6
26. Balsara BR, Pei J, De Rienzo A, Simon D, Tosolini A, Lu YY, Shen FM, Fan X, Lin WY, Buetow KH, et al: Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. Genes Chromosomes Cancer. 2001, 30: 245-253. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M. DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M
27. Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC: Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology. 1999, 29: 1208-1214. DOI: 10.1002/hep.510290410
28. Harada T, Shiraishi K, Kusano N, Umayahara K, Kondoh S, Okita K, Sasaki K: Evaluation of the reliability of chromosomal imbalances detected by combined use of universal DNA amplification and comparative genomic hybridization. Jpn J Cancer Res. 2000, 91: 1119-1125. DOI: 10.1111/j.1349-7006.2000.tb00894.x
29. Rao UN, Gollin SM, Beaves S, Cieply K, Nalesnik M, Michalopoulos GK: Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue. Mol Diagn. 2001, 6: 27-37. 10.1054/modi.2001.22021. DOI: 10.2165/00066982-200106010-00004
30. Takeo S, Arai H, Kusano N, Harada T, Furuya T, Kawauchi S, Oga A, Hirano T, Yoshida T, Okita K, Sasaki K: Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis. Cancer Genet Cytogenet. 2001, 130: 127-132. 10.1016/S0165-4608(01)00479-4. DOI: 10.1016/S0165-4608(01)00479-4
31. Kusano N, Okita K, Shirahashi H, Harada T, Shiraishi K, Oga A, Kawauchi S, Furuya T, Sasaki K: Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma. Cancer. 2002, 94: 746-751. 10.1002/cncr.10254. DOI: 10.1002/cncr.10254
32. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M, Inazawa J: TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology. 2002, 35: 1476-1484. DOI: 10.1053/jhep.2002.33683
33. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al: Gene expression patterns in human liver cancers. Mol Biol Cell. 2002, 13: 1929-1939. 10.1091/mbc.02-02-0023. DOI: 10.1091/mbc.02-02-0023.
34. Wong N, Lam WC, Lai PB, Pang E, Lau WY, Johnson PJ: Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol. 2001, 159: 465-471. DOI: 10.1016/S0002-9440(10)61718-X
35. Fujiwara Y, Ohata H, Kuroki T, Koyama K, Tsuchiya E, Monden M, Nakamura Y: Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene. 1995, 10: 891-895.
36. Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y: Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer. 1995, 72: 383-385. DOI: 10.1038/bjc.1995.342
37. CGMA - comparative analysis of microarray data. [http://www.vai.org/vari/downloads/development/clam-0.2.pl]
38. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863. DOI: 10.1073/pnas.95.25.14863